Research Article
Reduced Incidence and Better Liver Disease Outcomes among Chronic HCV Infected Patients Who Consume Cannabis
Table 2
Outcome characteristics by cannabis use status, after propensity matching.
| | No Cannabis use | Cannabis use | p-value |
| n | 4728 | 4728 | |
| Liver cirrhosis | 10.55 | 8.52 | 0.0014 |
| Ascites | 4.51 | 2.79 | <0.0001 |
| Variceal bleeding | 1.57 | 1.61 | 0.0258 |
| Hepatorenal syndrome | 0.49 | 0.38 | 0.4329 |
| Hepatic encephalopathy | 0.59 | 0.40 | 0.1964 |
| Portal hypertension | 2.92 | 2.07 | 0.0108 |
| Jaundice | 0.53 | 0.34 | 0.158 |
| Baveno4 scoring | | | 0.0019 | 0: No cirrhosis | 89.45 | 91.48 | | 1: Compensated cirrhosis | 5.31 | 4.72 | | 2: Decompensated cirrhosis | 5.25 | 3.81 | |
| Mortality | 1.65 | 1.27 | 0.119 |
| Liver cancer | 1.31 | 1.04 | 0.2282 |
| Discharge disposition | | | 0.0014 | Favourable discharge | 80.71 | 83.27 | | Unfavourable discharge | 19.29 | 16.73 | |
|
|